| |
|
|
|
Citius Pharmaceuticals Inc  
|
|
2.88 0.11 (0.04%) |
04-20 16:00 |
|
Open: |
2.83 |
Pre close: |
2.77 |
Target:
|
3.55
|
|
High: |
2.88 |
Low: |
2.76 |
Resistance:
|
3.04
3.37
|
|
Volume: |
20,269 |
Market Cap: |
31M |
Support:
|
2.50
2.08
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.86
 |
MACD |
MACD(12,26):
|
-0.11  |
|
MA(20): |
2.98 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
3.80 |
Stochastic Oscillator |
%K(14,3):
|
13.96 |
|
MA(250): |
0.00 |
%D(3): |
18.30 |
|
Average Volume(K) |
3-Month: |
3331
|
52-Week |
High:
|
6.60 |
|
10-Days: |
962 |
Low: |
2.50 |
|
RSI |
RSI(14):
|
41.84 |
Change(%): |
-58.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-55.8 |
Shares Out. (M) |
10.67 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-45.9 |
Shares Float (M) |
6.54 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
41.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.50 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
17 |
|
Book Value (p.s.) |
1.240 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.32 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.10 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-7.96 |
P/CF |
-3.38 |
|
|
|
|
|
|
